2021
DOI: 10.1016/j.pathol.2020.09.022
|View full text |Cite
|
Sign up to set email alerts
|

EBV positive fibrin/chronic inflammation associated diffuse large B-cell lymphoma: an incidental finding associated with a breast implant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(19 citation statements)
references
References 10 publications
0
16
0
3
Order By: Relevance
“…Nineteen of them developed in breast implants. 14,[26][27][28][29][30][31][32] Eight cases developed in thrombus, vegetation, or hematoma associated with an intravascular implant (7 being arterial graft, 8,10,20,22 1 being a bovine mitral valve 22 ). The 2 remaining cases developed after knee replacement.…”
Section: Discussionmentioning
confidence: 99%
“…Nineteen of them developed in breast implants. 14,[26][27][28][29][30][31][32] Eight cases developed in thrombus, vegetation, or hematoma associated with an intravascular implant (7 being arterial graft, 8,10,20,22 1 being a bovine mitral valve 22 ). The 2 remaining cases developed after knee replacement.…”
Section: Discussionmentioning
confidence: 99%
“…This DLBCL is a lymphoid neoplasm frequently associated with EBV infection, initially described in Japan, and arises in the setting of longstanding chronic inflammatory process such as chronic osteomyelitis, pyothorax, metallic implant, or chronic skin ulcers [ 2 , 44 ]. Furthermore, it was also described in ileal neobladder, and related to breast implants [ 109 , 110 , 111 ]. The neoplastic cells have immunoblastic, centroblastic, or less commonly anaplastic features, with few nucleoli and limited to moderate amounts of cytoplasm.…”
Section: Dlbcl Associated With Chronic Inflammationmentioning
confidence: 99%
“…NGS in a series of chronic inflammation DLBCL associated with breast implant described mutations in genes known to be recurrently mutated in DLBCL, such as CREBBP, GNA13, TET2, IRF4, STAT3, and SOCS1 [ 110 ]. Latency III program is prevalent, since viral oncogenic antigens EBERs, LMP1, and EBNA-2 are positive in most cases, which may be related to the pathogenesis of this particular DLBCL subtype [ 44 , 111 ]. Chronic inflammation at the local site perhaps plays a role in the proliferation of EBV-transformed B cells, since it allows them to escape from the host immune surveillance, as a result of the production of immunosuppressive IL10 cytokine, and the autocrine to paracrine growth via IL6 and IL6R [ 2 ].…”
Section: Dlbcl Associated With Chronic Inflammationmentioning
confidence: 99%
“…In den letzten Jahren wurden zusĂ€tzlich zum BIA-ALCL auch implantatassoziierte, diffus großzellige B-Zell-Lymphome (DLBCL) beschrieben, wie das brustimplantatassoziierte, EBV-positive, diffus großzellige B-Zell-Lymphom [44,45,46,47]. Diese sind meist negativ fĂŒr ALK, CD2, CD3, und B-Zell-Marker [48], jedoch u. a. CD20- [44,47,48,49], CD5-, BCL-2-, CD21-, CD23-, IgD-, IgM-positiv [49], im Falle von EBV-positiven, diffus großzelligen B-Zell-Lymphomen CD20-, CD30-, CD79a-, MUM1-und PAX-5-positiv [44,47,48] und Ă€hnlich zum BIA-ALCL in den meisten FĂ€llen mit texturierten Implantaten assoziiert [45,47]. In einem Fall wurde ein DLBCL jedoch auch nach Implantation eines glattwandigen Implantats beschrieben [50].…”
Section: Weitere Brustimplantatassoziierte Tumorenunclassified